Cutler Group’s GALENA BIOPHARMA INC COM RXII Stock Holding History

Cutler Group’s Portfolio RXII Stock Details RXII Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-20,014	Closed	-$7K	–	8013
2016 Q3	$7K	Hold	20,014	–	–	﹤0.01%	4704
2016 Q2	$9K	Hold	20,014	–	–	﹤0.01%	4366
2016 Q1	$27K	Sell	20,014 -1,900	-9%	-$2.56K	﹤0.01%	2988
2015 Q4	$32K	Buy	+21,914	New	+$32K	﹤0.01%	2946

Cutler Group's RXII Position: Q4 2016 in Review

Cutler Group sold out of GALENA BIOPHARMA INC COM (RXII) in Q4 2016, closing a stake of 20,014 shares — an estimated $7K sold.

Cutler Group first reported a position in RXII in Q4 2015 and held it in 4 quarters. The position peaked at $32K in Q4 2015. 0 funds tracked by Wall St. Rank hold RXII as of Q4 2016.

Cutler Group reported no remaining GALENA BIOPHARMA INC COM position as of Q4 2016 after selling out during the quarter.
Cutler Group sold 20,014 GALENA BIOPHARMA INC COM shares in Q4 2016, an estimated $7K.
Cutler Group first reported a position in GALENA BIOPHARMA INC COM in Q4 2015 and held it in 4 quarters.
Cutler Group's GALENA BIOPHARMA INC COM position peaked at $32K in Q4 2015.
0 funds tracked by Wall St. Rank held GALENA BIOPHARMA INC COM as of Q4 2016.

Based on Cutler Group's 13F filing for Q4 2016, filed 12 Jan 2017.